Last update 01 Nov 2024

Starna therapeutics

Private Company|
2021|
Jiangsu Sheng, China
|
www.starnatx.com

Overview

Tags

Respiratory Diseases
Infectious Diseases
Gene editing
mRNA vaccine

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Infectious Diseases1
Top 5 Drug TypeCount
Gene editing1
mRNA vaccine1

Related

2
Drugs associated with Starna therapeutics
STR-V003
Target-
Mechanism
Immunostimulants
Active Org.
Starna therapeutics
Originator Org.
Starna therapeutics
Active Indication
Respiratory Syncytial Virus Infections
Inactive Indication-
Drug Highest PhasePhase 1/2
First Approval Ctry. / Loc.-
First Approval Date-
MINIC RNA Editing(Shixi Biotechnology)
Target-
Mechanism-
Active Org.
Starna therapeutics [+1]
Originator Org.
Shixi (Guangzhou) Biotechnology Co., Ltd.
Active Indication
Lung Diseases
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Starna therapeutics
NCT06344975 / Not yet recruitingPhase 1/2
A Phase 1/2, Randomized, Placebo-Controlled, Double-Blind, Dose-Finding, First-in-Human Study of Respiratory Syncytial Virus (RSV) mRNA Vaccine STR-V003 in Healthy Adults
100 Clinical Results associated with Starna therapeutics
Login to view more data
0 Patents (Medical) associated with Starna therapeutics
Login to view more data
100 Deals associated with Starna therapeutics
Login to view more data
100 Translational Medicine associated with Starna therapeutics
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 24 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
1
1
Phase 2 Clinical
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
STR-V003
Respiratory Syncytial Virus Infections
More
Phase 2 Clinical
MINIC RNA Editing(Shixi Biotechnology)
Lung Diseases
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free